These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29704769)

  • 1. Generation of the induced pluripotent stem cell line CSSi006-A (3681) from a patient affected by advanced-stage Juvenile Onset Huntington's Disease.
    Rotundo G; Bidollari E; Ferrari D; Spasari I; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Migliore S; Squitieri F; Vescovi AL; Rosati J
    Stem Cell Res; 2018 May; 29():174-178. PubMed ID: 29704769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.
    HD iPSC Consortium
    Cell Stem Cell; 2012 Aug; 11(2):264-78. PubMed ID: 22748968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
    Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
    Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of an induced pluripotent stem cell line from a Huntington's disease patient with a long HTT-PolyQ sequence.
    Miller DC; Lisowski P; Genehr C; Wanker EE; Priller J; Prigione A; Diecke S
    Stem Cell Res; 2023 Apr; 68():103056. PubMed ID: 36863131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cell line, CSSi002-A (2851), from a patient with juvenile Huntington Disease.
    Rosati J; Bidollari E; Rotundo G; Ferrari D; Torres B; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Squitieri F; Vescovi AL
    Stem Cell Res; 2018 Mar; 27():86-89. PubMed ID: 29342448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington's Disease.
    Schultz JL; Moser AD; Nopoulos PC
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32825467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage.
    Bidollari E; Rotundo G; Ferrari D; Candido O; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Ilari A; Squitieri F; Vescovi AL; Rosati J
    Stem Cell Res; 2018 Apr; 28():145-148. PubMed ID: 29486399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.
    Naphade S; Tshilenge KT; Ellerby LM
    Neurotherapeutics; 2019 Oct; 16(4):979-998. PubMed ID: 31792895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells.
    Mollica PA; Zamponi M; Reid JA; Sharma DK; White AE; Ogle RC; Bruno RD; Sachs PC
    J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Clinical and Biological Characteristics in Juvenile-Onset Huntington's Disease.
    Schultz JL; Langbehn DR; Al-Kaylani HM; van der Plas E; Koscik TR; Epping EA; Espe-Pfeifer PB; Martin EP; Moser DJ; Magnotta VA; Nopoulos PC
    Mov Disord; 2023 Jan; 38(1):113-122. PubMed ID: 36318082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
    An MC; Zhang N; Scott G; Montoro D; Wittkop T; Mooney S; Melov S; Ellerby LM
    Cell Stem Cell; 2012 Aug; 11(2):253-63. PubMed ID: 22748967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?
    Squitieri F; Frati L; Ciarmiello A; Lastoria S; Quarrell O
    Mech Ageing Dev; 2006 Feb; 127(2):208-12. PubMed ID: 16274727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity.
    Camnasio S; Delli Carri A; Lombardo A; Grad I; Mariotti C; Castucci A; Rozell B; Lo Riso P; Castiglioni V; Zuccato C; Rochon C; Takashima Y; Diaferia G; Biunno I; Gellera C; Jaconi M; Smith A; Hovatta O; Naldini L; Di Donato S; Feki A; Cattaneo E
    Neurobiol Dis; 2012 Apr; 46(1):41-51. PubMed ID: 22405424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and genetic study of juvenile form of Huntington's disease].
    Zdzienicka E; Rakowicz M; Mierzewska H; Hoffman-Zacharska D; Jakubowska T; Poniatowska R; Sułek A; Waliniowska E; Zalewska U; Kulczycki J; Zaremba J
    Neurol Neurochir Pol; 2002; 36(2):245-58. PubMed ID: 12046502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
    Grigor'eva EV; Malankhanova TB; Surumbayeva A; Minina JM; Morozov VV; Abramycheva NY; Illarioshkin SN; Malakhova AA; Zakian SM
    Stem Cell Res; 2019 Jan; 34():101382. PubMed ID: 30658253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile-Onset Huntington's Disease in Peru: A Case Series of 32 Patients.
    Vishnevetsky A; Cornejo-Olivas M; Sarapura-Castro E; Inca-Martinez M; Rabinowitz D; Milla-Neyra K; Mazzetti P; Bird T
    Mov Disord Clin Pract; 2023 Feb; 10(2):238-247. PubMed ID: 36825038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.